SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiaodong Sun, Xiaoying Fu, Jie Li, Changsheng Xing, Henry F. Frierson, Hao Wu, Xiaokun Ding, Tongzhong Ju, Richard D. Cummings, Jin-Tang Dong, Deletion of Atbf1/Zfhx3 In Mouse Prostate Causes Neoplastic Lesions, Likely by Attenuation of Membrane and Secretory Proteins and Multiple Signaling Pathways, Neoplasia, 2014, 16, 5, 377

    CrossRef

  2. 2
    Veenu Tripathi, Nicholas C Popescu, Drazen B Zimonjic, DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions, SpringerPlus, 2014, 3, 1, 27

    CrossRef

  3. 3
    C Antognelli, I Palumbo, C Aristei, V N Talesa, Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB, British Journal of Cancer, 2014,

    CrossRef

  4. 4
    Serge Ginzburg, Konstantin V. Golovine, Petr B. Makhov, Robert G. Uzzo, Alexander Kutikov, Vladimir M. Kolenko, Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells, The Prostate, 2014, 74, 2
  5. 5
    Daniel P. Nguyen, Jinyi Li, Shalini S. Yadav, Ashutosh K. Tewari, Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer, BJU International, 2014, 114, 1
  6. 6
    Cinzia Antognelli, Letizia Mezzasoma, Katia Fettucciari, Vincenzo Nicola Talesa, A novel mechanism of methylglyoxal cytotoxicity in prostate cancer cells, The International Journal of Biochemistry & Cell Biology, 2013, 45, 4, 836

    CrossRef

  7. 7
    Y-R Kim, I-J Kim, T W Kang, C Choi, K K Kim, M S Kim, K I Nam, C Jung, HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis, Oncogene, 2013,

    CrossRef

  8. 8
    Adam H. Greer, Thomas Yong, Katie Fennell, Yara W. Moustafa, Marcie Fowler, Floyd Galiano, Shu-Wing Ng, Ross S. Berkowitz, James Cardelli, Shari Meyers, J. Nathan Davis, Knockdown of core binding factorβ alters sphingolipid metabolism, Journal of Cellular Physiology, 2013, 228, 12
  9. 9
    Stephen Y. W. Shiu, Wai Y. Leung, Chun W. Tam, Vincent W. S. Liu, Kwok-Ming Yao, Melatonin MT1 receptor-induced transcriptional up-regulation of p27Kip1 in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy, Journal of Pineal Research, 2013, 54, 1
  10. 10
    Juliana Y Koshimizu, Flávia L Beltrame, José P de Pizzol, Paulo S Cerri, Breno H Caneguim, Estela Sasso-Cerri, NF-kB overexpression and decreased immunoexpression of AR in the muscular layer is related to structural damages and apoptosis in cimetidine-treated rat vas deferens, Reproductive Biology and Endocrinology, 2013, 11, 1, 29

    CrossRef

  11. 11
    Kroeger N., Belldegrun A. S., Pantuck A. J., Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  12. 12
    Laura Campbell, Pamela Maxwell, David Waugh, Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer, Pharmaceuticals, 2013, 6, 8, 929

    CrossRef

  13. 13
    Cinzia Antognelli, Letizia Mezzasoma, Katia Fettucciari, Ettore Mearini, Vincenzo N. Talesa, Role of glyoxalase I in the proliferation and apoptosis control of human LNCaP and PC3 prostate cancer cells, The Prostate, 2013, 73, 2
  14. 14
    Joseph K. Hexum, Rodolfo Tello-Aburto, Nicholas B. Struntz, Andrew M. Harned, Daniel A. Harki, Bicyclic Cyclohexenones as Inhibitors of NF-κB Signaling, ACS Medicinal Chemistry Letters, 2012, 3, 6, 459

    CrossRef

  15. You have free access to this content15
    Konstantinos Tsapakidis, Panagiotis J Vlachostergios, Ioannis A Voutsadakis, Christina D Befani, Anna Patrikidou, Eleana Hatzidaki, Danai D Daliani, George Moutzouris, Panagiotis Liakos, Christos N Papandreou, Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells, International Journal of Urology, 2012, 19, 6
  16. 16
    Susanta Kar, Shreyasi Palit, Writoban Basu Ball, Pijush K. Das, Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells, Apoptosis, 2012, 17, 7, 735

    CrossRef

  17. 17
    P.-L. Kuo, K.-H. Shen, S.-H. Hung, Y.-L. Hsu, CXCL1/GRO  increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF- B/HDAC1 epigenetic regulation, Carcinogenesis, 2012, 33, 12, 2477

    CrossRef

  18. 18
    Anna Patrikidou, Panagiotis J Vlachostergios, Ioannis A Voutsadakis, Eleana Hatzidaki, Rosalia-Maria Valeri, Chariklia Destouni, Effie Apostolou, Christos N Papandreou, Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells, Cancer Cell International, 2012, 12, 1, 31

    CrossRef

  19. 19
    Shahnjayla K. Connors, Ganna Chornokur, Nagi B. Kumar, New Insights Into the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate Cancer, Nutrition and Cancer, 2012, 64, 1, 4

    CrossRef

  20. 20
    Garima Jain, Marcus V. Cronauer, Mark Schrader, Peter Möller, Ralf B. Marienfeld, NF-κB signaling in prostate cancer: A promising therapeutic target?, World Journal of Urology, 2012, 30, 3, 303

    CrossRef

  21. 21
    P McCall, L Bennett, I Ahmad, L M MacKenzie, I W G Forbes, H Y Leung, O J Sansom, C Orange, M Seywright, M A Underwood, J Edwards, NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression, British Journal of Cancer, 2012, 107, 9, 1554

    CrossRef

  22. 22
    Anna Hsu, Richard S. Bruno, Christiane V. Löhr, Alan W. Taylor, Rodrick H. Dashwood, Tammy M. Bray, Emily Ho, Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model, The Journal of Nutritional Biochemistry, 2011, 22, 5, 502

    CrossRef

  23. 23
    M. Ferrando, G. Gueron, B. Elguero, J. Giudice, A. Salles, F. Coluccio Leskow, E. A. Jares-Erijman, L. Colombo, R. Meiss, N. Navone, A. Siervi, E. Vazquez, Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer, Angiogenesis, 2011, 14, 4, 467

    CrossRef

  24. 24
    Jinfeng Han, Sherryline Jogie-Brahim, Aki Harada, Youngman Oh, Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling, Cancer Letters, 2011, 307, 2, 200

    CrossRef

  25. 25
    Anna Patrikidou, Panagiotis J Vlachostergios, Ioannis A Voutsadakis, Eleana Hatzidaki, Rosalia-Maria Valeri, Chariklia Destouni, Effie Apostolou, Danai Daliani, Christos N Papandreou, Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells, Cancer Cell International, 2011, 11, 1, 13

    CrossRef

  26. 26
    David Heber, Herbal Medicine, 2011,

    CrossRef

  27. You have open access to this content27
    Wunchana Seubwai, Kulthida Vaeteewoottacharn, Masateru Hiyoshi, Shinya Suzu, Anucha Puapairoj, Chairisi Wongkham, Seiji Okada, Sopit Wongkham, Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB, Cancer Science, 2010, 101, 7
  28. 28
    Stylianos Kontos, Georgia Sotiropoulou-Bonikou, Athina Kominea, Maria Melachrinou, Eleni Balampani, Dionysis Bonikos, Coordinated Increased Expression of Cyclooxygenase2 and Nuclear Factor ��B Is a Steady Feature of Urinary Bladder Carcinogenesis, Advances in Urology, 2010, 2010, 1

    CrossRef

  29. You have open access to this content29
    Tisheeka R. Graham, Krishna C. Agrawal, Asim B. Abdel-Mageed, Independent and cooperative roles of tumor necrosis factor-α, nuclear factor-κB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells, Cancer Science, 2010, 101, 1
  30. You have free access to this content30
    Stylianos Kontos, Athina Kominea, Maria Melachrinou, Eleni Balampani, Georgia Sotiropoulou-Bonikou, Inverse expression of estrogen receptor-β and nuclear factor-κB in urinary bladder carcinogenesis, International Journal of Urology, 2010, 17, 9
  31. 31
    Qinghang Meng, Zhimin Peng, Liang Chen, Jutong Si, Zhongyun Dong, Ying Xia, Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells, Cancer Letters, 2010, 299, 1, 45

    CrossRef

  32. 32
    Aaron K. Holley, Yong Xu, Daret K. St. Clair, William H. St. Clair, RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells, Annals of the New York Academy of Sciences, 2010, 1201, 1
  33. 33
    I Echchgadda, S Kota, I DeLa Cruz, A Sabbah, T Chang, R Harnack, V Mgbemena, B Chatterjee, S Bose, Anticancer oncolytic activity of respiratory syncytial virus, Cancer Gene Therapy, 2009, 16, 12, 923

    CrossRef

  34. 34
    Sri Balasubashini Muralimanoharan, A.B. Kunnumakkara, Bhaskaran Shylesh, Kaustubh H. Kulkarni, Xu Haiyan, Hu Ming, Bharat B. Aggarwal, Ghosh Rita, Addanki P. Kumar, Butanol fraction containing berberine or related compound from nexrutine® inhibits NFκB signaling and induces apoptosis in prostate cancer cells, The Prostate, 2009, 69, 5
  35. 35
    Myoung H. Kim, Alena Z. Minton, Vikas Agrawal, C/EBPβ regulates metastatic gene expression and confers TNF-α resistance to prostate cancer cells, The Prostate, 2009, 69, 13
  36. 36
    S. E. Wurster, J. P. Bida, Y. F. Her, L. J. Maher, Characterization of anti-NF- B RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system, Nucleic Acids Research, 2009, 37, 18, 6214

    CrossRef

  37. 37
    S. A. Sarkar, B. Kutlu, K. Velmurugan, S. Kizaka-Kondoh, C. E. Lee, R. Wong, A. Valentine, H. W. Davidson, J. C. Hutton, S. Pugazhenthi, Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-κB) signalling in human islets and in a mouse beta cell line, Diabetologia, 2009, 52, 6, 1092

    CrossRef

  38. 38
    Tisheeka R. Graham, Valerie A. Odero-Marah, Leland W. Chung, Krishna C. Agrawal, Rodney Davis, Asim B. Abdel-Mageed, PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-κB in metastatic prostate cancer cells, The Prostate, 2009, 69, 2
  39. 39
    Dixan A. Benitez, Marcela A. Hermoso, Eulalia Pozo-Guisado, Pedro M. Fernández-Salguero, Enrique A. Castellón, Regulation of cell survival by resveratrol involves inhibition of NFκB-regulated gene expression in prostate cancer cells, The Prostate, 2009, 69, 10
  40. 40
    H. J. You, T. How, G. C. Blobe, The type III transforming growth factor-  receptor negatively regulates nuclear factor kappa B signaling through its interaction with  -arrestin2, Carcinogenesis, 2009, 30, 8, 1281

    CrossRef

  41. 41
    Hla Y. Win, Mildred Acevedo-Duncan, Atypical protein kinase C phosphorylates IKKαβ in transformed non-malignant and malignant prostate cell survival, Cancer Letters, 2008, 270, 2, 302

    CrossRef

  42. 42
    Thangaiyan Rabi, Sanjeev Shukla, Sanjay Gupta, Betulinic acid suppresses constitutive and TNFα-induced NF-κB activation and induces apoptosis in human prostate carcinoma PC-3 cells, Molecular Carcinogenesis, 2008, 47, 12
  43. 43
    Georgia Levidou, Angelica A. Saetta, Penelope Korkolopoulou, Polyanthi Papanastasiou, Katerina Gioti, Petros Pavlopoulos, Kalliopi Diamantopoulou, Eupthemia Thomas-Tsagli, Konstantinos Xiromeritis, Efstratios Patsouris, Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder, Virchows Archiv, 2008, 452, 3, 295

    CrossRef

  44. 44
    Konstantin Golovine, Robert G. Uzzo, Peter Makhov, Paul L. Crispen, David Kunkle, Vladimir M. Kolenko, Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-κB-dependent pathway, The Prostate, 2008, 68, 13
  45. 45
    Hui-Qing Yuan, Feng Kong, Xiao-Ling Wang, Charles Y.F. Young, Xiao-Yan Hu, Hong-Xiang Lou, Inhibitory effect of acetyl-11-keto-β-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells, Biochemical Pharmacology, 2008, 75, 11, 2112

    CrossRef

  46. 46
    David Heber, Multitargeted therapy of cancer by ellagitannins, Cancer Letters, 2008, 269, 2, 262

    CrossRef

  47. 47
    Jean-François Jeannin, Lissbeth Leon, Marion Cortier, Néjia Sassi, Catherine Paul, Ali Bettaieb, Nitric oxide-induced resistance or sensitization to death in tumor cells, Nitric Oxide, 2008, 19, 2, 158

    CrossRef

  48. 48
    Hai-Yen Vu, Ashish Juvekar, Chandra Ghosh, Sitharam Ramaswami, Dung Hong Le, Ivana Vancurova, Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IκBα, Archives of Biochemistry and Biophysics, 2008, 475, 2, 156

    CrossRef

  49. 49
    Imtiaz A. Siddiqui, Yogeshwer Shukla, Vaqar M. Adhami, Sami Sarfaraz, Mohammad Asim, Bilal Bin Hafeez, Hasan Mukhtar, Suppression of NFκB and its Regulated Gene Products by Oral Administration of Green Tea Polyphenols in an Autochthonous Mouse Prostate Cancer Model, Pharmaceutical Research, 2008, 25, 9, 2135

    CrossRef

  50. 50
    Lingfei Wu, Zejin Pu, Jialin Feng, Guoping Li, Zhichao Zheng, Wenlv Shen, The ubiquitin-proteasome pathway and enhanced activity of NF-κB in gastric carcinoma, Journal of Surgical Oncology, 2008, 97, 5
  51. 51
    C Nuñez, J R Cansino, F Bethencourt, M Pérez-Utrilla, B Fraile, P Martínez-Onsurbe, G Olmedilla, R Paniagua, M Royuela, TNF/IL-1/NIK/NF-κB transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma), Histopathology, 2008, 53, 2
  52. 52
    Everson Araújo Nunes, Diogo Kuczera, Gleisson Alisson Pereira Brito, Sandro J.R. Bonatto, Ricardo Key Yamazaki, Ricardo Antonio Tanhoffer, Rogéria Campus Mund, Marcelo Kryczyk, Luiz Claudio Fernandes, β-Hydroxy-β-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-κB expression, Nutrition Research, 2008, 28, 7, 487

    CrossRef

  53. 53
    Yarí E. Marín, Brian A. Wall, Su Wang, Jin Namkoong, Jeffrey J. Martino, Junghan Suh, Hwa Jin Lee, Arnold B. Rabson, Chung S. Yang, Suzie Chen, Jae-Ha Ryu, Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells, Melanoma Research, 2007, 17, 5, 274

    CrossRef

  54. 54
    Mei-lan HE, Ang LI, Chun-su XU, Shun-li WANG, Meng-jie ZHANG, Hua GU, Yao-qin YANG, Hui-hong TAO, Mechanisms of antiprostate cancer by gum mastic: NF-κB signal as target, Acta Pharmacologica Sinica, 2007, 28, 3
  55. 55
    Laurent Lessard, Fred Saad, Cécile Le Page, Jean-Simon Diallo, Benjamin Péant, Nathalie Delvoye, Anne-Marie Mes-Masson, NF-κB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells, Cellular Signalling, 2007, 19, 5, 1093

    CrossRef

  56. 56
    V. Fernandez-Majada, C. Aguilera, A. Villanueva, F. Vilardell, A. Robert-Moreno, A. Aytes, F. X. Real, G. Capella, M. W. Mayo, L. Espinosa, A. Bigas, Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer, Proceedings of the National Academy of Sciences, 2007, 104, 1, 276

    CrossRef

  57. 57
    Bernard Paule, Stéphane Terry, Laurence Kheuang, Pascale Soyeux, Francis Vacherot, Alexandre Taille, The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?, World Journal of Urology, 2007, 25, 5, 477

    CrossRef

  58. 58
    Paul L. Crispen, Robert G. Uzzo, Konstantin Golovine, Peter Makhov, Alan Pollack, Eric M. Horwitz, Richard E. Greenberg, Vladimir M. Kolenko, Vitamin E succinate inhibits NF-κB and prevents the development of a metastatic phenotype in prostate cancer cells: Implications for chemoprevention, The Prostate, 2007, 67, 6
  59. 59
    Emily C. Colgate, Cristobal L. Miranda, Jan F. Stevens, Tammy M. Bray, Emily Ho, Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells, Cancer Letters, 2007, 246, 1-2, 201

    CrossRef

  60. 60
    Jean-Simon Diallo, Benjamin Péant, Laurent Lessard, Nathalie Delvoye, Cécile Le Page, Anne-Marie Mes-Masson, Fred Saad, An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines, The Prostate, 2006, 66, 12
  61. 61
    K De Bosscher, W Vanden Berghe, G Haegeman, Cross-talk between nuclear receptors and nuclear factor κB, Oncogene, 2006, 25, 51, 6868

    CrossRef

  62. 62
    Alex B Lentsch, CXC chemokines and prostate cancer: growth regulators and potential biomarkers, Future Oncology, 2006, 2, 5, 651

    CrossRef

  63. 63
    J.-H. Kim, C. Xu, Y.-S. Keum, B. Reddy, A. Conney, A.-N. T. Kong, Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with  -phenylethyl isothiocyanate and curcumin, Carcinogenesis, 2006, 27, 3, 475

    CrossRef

  64. 64
    Koh Takeyama, Hiroaki Mitsuzawa, Takeyuki Shimizu, Masanori Konishi, Chiaki Nishitani, Hitomi Sano, Yasuharu Kunishima, Masanori Matsukawa, Satoshi Takahashi, Ken-ichiro Shibata, Taiji Tsukamoto, Yoshio Kuroki, Prostate cell lines secrete IL-8 in response to mycoplasma hominis through Toll-like receptor 2-mediated mechanism, The Prostate, 2006, 66, 4
  65. 65
    G. Prem Veer Reddy, Evelyn R. Barrack, Q. Ping Dou, Mani Menon, Ronald Pelley, Fazlul H. Sarkar, Shijie Sheng, Regulatory processes affecting androgen receptor expression, stability, and function: Potential targets to treat hormone-refractory prostate cancer, Journal of Cellular Biochemistry, 2006, 98, 6
  66. 66
    S M Majid, A S Liss, M You, H R Bose, The suppression of SH3BGRL is important for v-Rel-mediated transformation, Oncogene, 2006, 25, 5, 756

    CrossRef

  67. 67
    Hsin-Ching Lin, Michele Hickey, Lydia Hsu, Daniel Medina, Arnold B. Rabson, Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression, Virology, 2005, 339, 1, 1

    CrossRef

  68. 68
    J Domingo-Domenech, B Mellado, B Ferrer, D Truan, J Codony-Servat, S Sauleda, J Alcover, E Campo, P Gascon, A Rovira, J S Ross, P L Fernández, J Albanell, Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse, British Journal of Cancer, 2005, 93, 11, 1285

    CrossRef

  69. 69
    Sanjeev Shukla, Gregory T. MacLennan, Susan R. Marengo, Martin I. Resnick, Sanjay Gupta, Constitutive activation of PI3K-Akt and NF-κB during prostate cancer progression in autochthonous transgenic mouse model, The Prostate, 2005, 64, 3
  70. 70
    Q. Li, Y.-Y. Yu, Z.-G. Zhu, Y.-B. Ji, Y. Zhang, B.-Y. Liu, X.-H. Chen, Y.-Z. Lin, Effect of NF-κB Constitutive Activation on Proliferation and Apoptosis of Gastric Cancer Cell Lines, European Surgical Research, 2005, 37, 2, 105

    CrossRef

  71. 71
    A Yemelyanov, A Gasparian, P Lindholm, L Dang, J W Pierce, F Kisseljov, A Karseladze, I Budunova, Effects of IKK inhibitor PS1145 on NF-κB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells, Oncogene, 2005,

    CrossRef

  72. 72
    Cécile Le Page, Ismael Hervé Koumakpayi, Laurent Lessard, Anne-Marie Mes-Masson, Fred Saad, EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells, The Prostate, 2005, 65, 2
  73. 73
    Yang Yang, Takayuki Ikezoe, Tamotsu Takeuchi, Yoshihiro Adachi, Yuji Ohtsuki, Seisho Takeuchi, H. Phillip Koeffler, Hirokuni Taguchi, HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling, Cancer Science, 2005, 96, 7
  74. 74
    Faribourz Payvandi, Lei Wu, Syedah D. Naziruddin, Maura Haley, Anastasia Parton, Peter H. Schafer, Roger S. Chen, George W. Muller, Christopher C.W. Hughes, David I. Stirling, Immunomodulatory Drugs (IMiDs) Increase the Production of IL-2 from Stimulated T Cells by Increasing PKC-θ Activation and Enhancing the DNA-Binding Activity of AP-1 but Not NF-κB, OCT-1, or NF-AT, Journal of Interferon & Cytokine Research, 2005, 25, 10, 604

    CrossRef

  75. 75
    Vladimir L Gabai, Karine R Budagova, Michael Y Sherman, Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents, Oncogene, 2005, 24, 20, 3328

    CrossRef

  76. 76
    Cécile Le Page, Ismael Hervé Koumakpayi, Laurent Lessard, Fred Saad, Anne-Marie Mes-Masson, Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-kappaB activation in prostate cancer cells, The Prostate, 2005, 65, 4
  77. 77
    Y.Y. Yu, Q. Li, Z.G. Zhu, NF-κB as a molecular target in adjuvant therapy of gastrointestinal carcinomas, European Journal of Surgical Oncology (EJSO), 2005, 31, 4, 386

    CrossRef

  78. 78
    L Lessard, L R Bégin, M E Gleave, A-M Mes-Masson, F Saad, Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study, British Journal of Cancer, 2005, 93, 9, 1019

    CrossRef

  79. 79
    Kwanchanit Tantivejkul, Robert D. Loberg, Samkeliso C. Mawocha, Lashon L. Day, Lauren St. John, Brian A. Pienta, Mark A. Rubin, Kenneth J. Pienta, PAR1-mediated NFκB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism, Journal of Cellular Biochemistry, 2005, 96, 3
  80. 80
    Soo Ok Lee, Wei Lou, Nagalakshmi Nadiminty, Xin Lin, Allen C. Gao, Requirement for NF-κB in interleukin-4-induced androgen receptor activation in prostate cancer cells, The Prostate, 2005, 64, 2
  81. 81
    Changjiang Xu, Guoxiang Shen, Chi Chen, Céline Gélinas, Ah-Ng Tony Kong, Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells, Oncogene, 2005, 24, 28, 4486

    CrossRef

  82. 82
    Rana P. Singh, Rajesh Agarwal, A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2004, 555, 1-2, 21

    CrossRef

  83. 83
    Lone Stengelshøj Olsen, Pernille-Julia Vig Hjarnaa, Scilla Latini, Pernille Kaae Holm, Rolf Larsson, Erik Bramm, Lise Binderup, Mogens Winkel Madsen, Anticancer agent CHS 828 suppresses nuclear factor-κB activity in cancer cells through downregulation of IKK activity, International Journal of Cancer, 2004, 111, 2
  84. 84
    Natalya V. Guseva, Agshin F. Taghiyev, Oskar W. Rokhlin, Michael B. Cohen, Death receptor-induced cell death in prostate cancer, Journal of Cellular Biochemistry, 2004, 91, 1
  85. 85
    Hazem Ismail A., Laurent Lessard, Anne-Marie Mes-Masson, Fred Saad, Expression of NF-κB in prostate cancer lymph node metastases, The Prostate, 2004, 58, 3
  86. 86
    Ganesh V. Raj, Jeffrey A. Sekula, Rishu Guo, John F. Madden, Yehia Daaka, Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-κB, The Prostate, 2004, 61, 2
  87. 87
    Junghan Suh, Arnold B. Rabson, NF-κB activation in human prostate cancer: Important mediator or epiphenomenon?, Journal of Cellular Biochemistry, 2004, 91, 1
  88. 88
    Sanjeev Shukla, Gregory T. MacLennan, Pingfu Fu, Jigar Patel, Susan R. Marengo, Martin l. Resnick, Sanjay Gupta, Nuclear Factor-κB/p65 (Rel A) Is Constitutively Activated in Human Prostate Adenocarcinoma and Correlates with Disease Progression, Neoplasia, 2004, 6, 4, 390

    CrossRef

  89. 89
    E. C. Y. LEE, M. TENNISWOOD, PROGRAMMED CELL DEATH AND SURVIVAL PATHWAYS IN PROSTATE CANCER CELLS, Systems Biology in Reproductive Medicine, 2004, 50, 1, 27

    CrossRef

  90. 90
    Takayuki Ikezoe, Yang Yang, Tsuyako Saito, H. Phillip Koeffler, Hirokuni Taguchi, Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells, Cancer Science, 2004, 95, 3
  91. 91
    Keiji Shimada, Mitsutoshi Nakamura, Eiwa Ishida, Munehiro Kishi, Syuchi Matsuyoshi, Noboru Konishi, The molecular mechanism of sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in PC3 prostate cancer cells, Molecular Carcinogenesis, 2004, 39, 1
  92. 92
    Thambi Dorai, Janice P. Dutcher, David W. Dempster, Peter H. Wiernik, Therapeutic potential of curcumin in prostate cancer—IV: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells, The Prostate, 2004, 60, 1
  93. 93
    Addanki P. Kumar, Gretchen E. Garcia, Rita Ghosh, Rajendran V. Rajnarayanan, William L. Alworth, Thomas J. Slaga, 4-Hydroxy-3-Methoxybenzoic Acid Methyl Ester: A Curcumin Derivative Targets Akt/NFκB Cell Survival Signaling Pathway: Potential for Prostate Cancer Management, Neoplasia, 2003, 5, 3, 255

    CrossRef

  94. 94
    Asit K Chakraborty, Salil K Das, Molecular cloning and characterization of the guinea pig cholinephosphotransferase gene, Biochemical and Biophysical Research Communications, 2003, 312, 4, 1104

    CrossRef

  95. 95
    L. Lessard, A.-M. Mes-Masson, L. Lamarre, L. Wall, J.-B. Lattouf, F. Saad, NF-κB nuclear localization and its prognostic significance in prostate cancer, BJU International, 2003, 91, 4
  96. 96
    Aparajita Ghosh, Jacqueline Akech, Shyamali Mukherjee, Salil K Das, Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells, Biochemical and Biophysical Research Communications, 2002, 297, 4, 1043

    CrossRef